Burnett immunology centre gets nod from NATA
Thursday, 03 June, 2010
The Burnett Institute’s ImmunoMonitoring Facility (IMF) has become first such facility in Victoria, and only the fifth in Australia, to be accredited by the National Association of Testing Authorities of Australia.
Associate Professor Rosemary French, founder of the IMF said that the accreditation represents an important milestone for the Victorian biotech industry and is expected to greatly advance the development of novel vaccines for diseases such as HIV and hepatitis C.
“The IMF will produce high quality data on the action of these new agents which will assist in obtaining regulatory authority approval to progress in clinical trials and eventual licensing of new vaccines,” she said. “It will also assist the local Victorian biotechnology industry in testing vaccines and immunotherapies in pre-clinical development.”
Development of the IMF was assisted by a grant from the Helen Macpherson Smith Trust.
Research project to produce fish-free omega-3
SCU researchers are investigating how to grow omega-3-producing microorganisms more cheaply...
Biodegradable smart patch can detect and treat blood clots
Researchers have developed a biodegradable smart patch that detects pressure changes and releases...
Biotech manufacturing facility opens in Brisbane
ENTRI, a purpose-built multimodal facility which will enable biotech companies to manufacture...
